XTANT MEDICAL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.30% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-03-06
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.70%.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2018-03-31 was 0.00%.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-03-31 was 2.37%, a 0.42% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-03-31 was 2.38%, a 161.54% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.30%, a 22.86% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 3.50%, a 260.82% increase from fiscal 2021.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.97%, a 79.63% increase from fiscal 2020.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.54%, a 70.33% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | 4.30% 10-K · filed 2025-03-06 | ||||||
| 2022-12-31 | 3.50% 10-K · filed 2024-04-01 | ||||||
| 2021-12-31 | 0.97% 10-K · filed 2023-03-07 | ||||||
| 2020-12-31 | 0.54% 10-K · filed 2022-03-08 | ||||||
| 2019-12-31 | 1.82% 10-K · filed 2021-02-24 | ||||||
| 2019-09-30 | 2.20% 10-Q · filed 2019-11-07 | ||||||
| 2019-06-30 | 2.70% 10-Q · filed 2019-08-08 | ||||||
| 2019-03-31 | 2.70% 10-Q · filed 2019-05-15 | ||||||
| 2018-12-31 | 2.97% 10-K · filed 2020-03-05 | 2.48% 10-K · filed 2019-04-01 | |||||
| 2018-09-30 | 2.90% 10-Q · filed 2019-11-07 | 2.10% 10-Q · filed 2018-11-14 | |||||
| 2018-06-30 | 0.00% 10-Q · filed 2019-08-08 | 2.62% 10-Q · filed 2018-08-08 | |||||
| 2018-03-31 | 0.00% 10-Q · filed 2019-05-15 | ||||||
| 2017-12-31 | 2.12% 10-K · filed 2019-04-01 | ||||||
| 2017-09-30 | 1.85% 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | 1.85% 10-Q · filed 2018-08-08 | ||||||
| 2016-12-31 | 1.49% 10-K · filed 2017-03-29 | ||||||
| 2016-09-30 | 2.21% 10-Q · filed 2016-11-10 | ||||||
| 2016-06-30 | 1.99% 10-Q · filed 2016-08-10 | ||||||
| 2016-03-31 | 2.37% 10-Q · filed 2016-05-11 | ||||||
| 2015-12-31 | 1.75% 10-K · filed 2017-03-29 | ||||||
| 2015-09-30 | 1.30% 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | 1.75% 10-Q · filed 2016-08-10 | ||||||
| 2015-03-31 | 2.38% 10-Q · filed 2016-05-11 | ||||||
| 2014-12-31 | 1.92% 10-K · filed 2016-03-24 | ||||||
| 2014-09-30 | 1.81% 10-Q · filed 2015-11-16 | ||||||
| 2014-06-30 | 1.76% 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | 0.91% 10-Q · filed 2015-05-06 | ||||||
| 2013-12-31 | 1.16% 10-K · filed 2015-03-18 | ||||||
| 2013-09-30 | 1.68% 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | 1.12% 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |